Steven Wexner, Editor In Chief at Surgery, shared on X about a recent paper by Rachel Gefen et al. published on ScienceDirect:
“Medical therapies to prevent relapse of Crohn’s disease after surgery..”
Title: Medical therapies to prevent relapse of Crohn’s disease after surgery: A systematic review and network meta-analysis
Authors: Rachel Gefen, Shani Y. Parnasa, Sameh Hany Emile, Nir Horesh, Justin Dourado, Zoe Garoufalia, Anjelli Wignakumar, Marylise Boutros, Steven D. Wexner
Hassan R. Hashmi, General and Colorectal Surgeon at LVSA, shared Steven D Wexner’s post:
“PRISMA-compliant systematic review & network meta-analysis on Crohn’s recurrence post-surgery: adalimumab ranked highest, infliximab second. Both reduced recurrence vs placebo, though adalimumab had higher severe AE risk. Key data for risk–benefit decisions.”
More posts featuring Steven D. Wexner and Hassan R. Hashmi.